|
|
A role for the complement system in seizure induced neuronal and dendritic injury |
| 5R01NS096234-02 |
BREWSTER, AMY L |
NIAID |
2020 |
|
|
Examining the role of brain sodium content in multiplesclerosis using MRI |
| 5R01NS099527-04 |
LUBLIN, FRED D |
NIAID |
2020 |
|
|
In vivo assessment of meningeal inflammation and its clinical impact in multiple sclerosis by 7 Tesla MRI |
| 5R01NS104403-03 |
HARRISON, DANIEL M |
NIAID |
2020 |
|
|
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach |
| 5R01NS109670-03 |
VOSKUHL, RHONDA R |
NIAID |
2020 |
|
|
REGULATION OF TH17 PLASTICITY AND STEMNESS BY MTORC1 |
| 3R01AI131703-02S1 |
CHI, HONGBO |
NIAID |
2019 |
|
|
SHEDDING, RETENTION AND SPREADING OF CHRONIC WASTE DISEASE PRIONS IN THE ENVIRONMENT |
| 3R01AI132695-03S1 |
MORALES, RODRIGO |
NIAID |
2019 |
|
|
LONG NON-CODING RNA SIGNATURES TO CLASSIFY MULTIPLE SCLEROSIS |
| 5R44AI124766-03 |
SPURLOCK, CHARLES FLOYD |
NIAID |
2018 |
|
|
MODULATION OF THE INNATE IMMUNE RESPONSE BY FISETIN DERIVATIVES FOR THE TREATMENT OF AD |
| 5R42AI104034-04 |
MAHER, PAMELA ANNE |
NIAID |
2017 |
|
|
PRION DISEASE THERAPEUTICS |
| 1ZIAAI001087-07 |
CAUGHEY, BYRON |
NIAID |
2016 |
|
|
MOLECULAR MECHANISMS OF PRION PROTEIN AMYLOID FORMATION |
| 1ZIAAI001105-08 |
PRIOLA, SUZETTE ALISE |
NIAID |
2016 |
